Malignant Mixed Mullerian Tumor  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00476086: Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus

Completed
2
20
US
Gemcitabine, Gemzar, Oxaliplatin, Eloxatin, Radiation
Dana-Farber Cancer Institute, Sanofi, Brigham and Women's Hospital, Massachusetts General Hospital
Mixed Mullerian Tumors of the Uterus
03/12
12/15

Download Options